| Drugs by Condition |  |
Myelodysplastic Syndrome Medications
Definition of Myelodysplastic Syndrome: A group of disorders characterised by low white blood cell counts, low platelet counts, and, in some cases, increased monocytes. The primary problem is in the bone marrow cellularity.
Drugs associated with Myelodysplastic Syndrome
The following drugs and medications are in some way related to, or used in the treatment of Myelodysplastic Syndrome. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Drug Name  ( View by: Brand | Generic )
|
Reviews | Ratings |
||
|---|---|---|---|---|
Neupogen (Pro, More...) generic name: filgrastim class: colony stimulating factors | 0 review(s) | Not rated - Be the first | ||
| Vidaza (Pro, More...)generic name: azacitidine class: miscellaneous antineoplastics | 2 review(s) |  | 3.5 | |
| Dacogen (More...)generic name: decitabine class: antimetabolites | 0 review(s) | Not rated - Be the first | ||
| Thymoglobulin (More...)generic name: lymphocyte immune globulin, anti-thymocyte class: immune globulins | 0 review(s) | Not rated - Be the first | ||
| Atgam (More...)generic name: lymphocyte immune globulin, anti-thymocyte class: immune globulins | 0 review(s) | Not rated - Be the first | ||
Latest Myelodysplastic Syndrome Blog Post
Data Published in The Lancet Oncology Further Substantiates VIDAZA's Extended Survival Benefit for MDS Patients
WASHINGTON--(BUSINESS WIRE)--Feb 18, 2009 - The Aplastic Anemia & MDS International Foundation says that data from the AZA-001 clinical trial, published today in The Lancet Oncology, demonstrated that VIDAZA is the only non-transplant treatment that extends...
View all Myelodysplastic Syndrome blog posts.
